Healthy volunteers in Kansas City, Missouri and Philadelphia will begin to test an experimental coronavirus vaccine starting on Monday officials said.
The vaccine is sponsored by none other than Bill Gates Foundation.
A small Pennsylvania-based biotech Inovio Pharmaceuticals received regulatory clearance to begin testing. The Bill and Melinda Gates Foundation, along with other nonprofits, have poured funding into Inovio’s vaccine project.
The biotech expects to have early safety data by later summer and is aiming to produce 1 million doses by the end of 2020.
For the study the company will be enrolling 40 healthy adult participants in Philadelphia at the University of Pennsylvania’s medical school and in Kansas City, Missouri, at the Center for Pharmaceutical Research.
Each of the volunteers will take two doses of the vaccine, four weeks apart.